吡哆胺
吡哆胺(英語:Pyridoxamine),分子式C8H12N2O2,是一種被稱為維他命B6的化合物之一,另外兩個分別是:吡哆醛與吡哆醇,它與吡哆醇的不同在於4位取代基為氨甲基而非羥甲基[1]。
吡哆胺 | |
---|---|
IUPAC名 4-(Aminomethyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol | |
識別 | |
CAS號 | 85-87-0 |
PubChem | 1052 |
ChemSpider | 1023 |
SMILES |
|
InChI |
|
InChIKey | NHZMQXZHNVQTQA-UHFFFAOYAS |
ChEBI | 16410 |
KEGG | C00534 |
性質 | |
化學式 | C8H12N2O2 |
摩爾質量 | 168.19 g·mol−1 |
若非註明,所有數據均出自標準狀態(25 ℃,100 kPa)下。 |
參考文獻
編輯- ^ Adrover M, Vilanova B, Frau J, Muñoz F, Donoso J. The pyridoxamine action on Amadori compounds: A reexamination of its scavenging capacity and chelating effect. Bioorg. Med. Chem. May 2008, 16 (10): 5557–69. PMID 18434162. doi:10.1016/j.bmc.2008.04.002.
外部連結
編輯- Clinical trials testing Pyridoxamine (clinicaltrials.gov):
- Effect of Pyridorin in Patients With Diabetic Nephropathy (頁面存檔備份,存於互聯網檔案館) (NCT00320060)
- Effect of Pyridorin in Patients With Diabetic Nephropathy (頁面存檔備份,存於互聯網檔案館) (NCT00320021)
- Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes (頁面存檔備份,存於互聯網檔案館) (NCT00734253)